Total Payments
$6,043
2024 Payments
$1,752
Companies
42
Transactions
321
Medicare Patients
730
Medicare Billing
$78,034
Payment Breakdown by Category
Food & Beverage$6,043 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,043 | 321 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,047 | 57 | $0 (2024) |
| ABBVIE INC. | $757.79 | 43 | $0 (2024) |
| GlaxoSmithKline, LLC. | $458.74 | 24 | $0 (2024) |
| PFIZER INC. | $403.53 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $253.48 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $233.70 | 11 | $0 (2024) |
| Dynavax Technologies Corporation | $228.04 | 11 | $0 (2024) |
| Dexcom, Inc. | $221.86 | 8 | $0 (2024) |
| Exact Sciences Corporation | $207.05 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $196.66 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,752 | 84 | Novo Nordisk Inc ($283.47) |
| 2023 | $1,897 | 102 | ABBVIE INC. ($404.35) |
| 2022 | $1,020 | 52 | Novo Nordisk Inc ($202.52) |
| 2021 | $259.15 | 12 | DEXCOM, INC. ($83.90) |
| 2020 | $60.21 | 3 | Genentech USA, Inc. ($37.56) |
| 2019 | $445.27 | 28 | Novo Nordisk Inc ($88.93) |
| 2018 | $175.07 | 12 | Novo Nordisk Inc ($39.13) |
| 2017 | $434.41 | 28 | AstraZeneca Pharmaceuticals LP ($122.48) |
All Payment Transactions
321 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Gastroenterology | ||||||
| 12/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Obesity | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: VACCINES | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | SANOFI PASTEUR INC. | FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $35.33 | General |
| Category: Vaccines | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Oncology | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: Hepatitis B Vaccine | ||||||
| 11/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.68 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Diabetes Care | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: VACCINE | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Cardio-renal | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Cardio-renal | ||||||
| 09/30/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: VACCINE | ||||||
| 09/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Obesity | ||||||
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: DIABETES | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 270 | 292 | $77,448 | $32,514 |
| 2022 | 10 | 209 | 224 | $51,540 | $22,436 |
| 2021 | 6 | 141 | 181 | $33,294 | $14,727 |
| 2020 | 6 | 110 | 122 | $23,417 | $8,357 |
Total Patients
730
Total Services
819
Medicare Billing
$78,034
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 34 | 34 | $18,666 | $9,580 | 51.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 67 | 67 | $18,961 | $9,135 | 48.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 65 | $18,070 | $5,613 | 31.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 24 | $9,456 | $3,293 | 34.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 19 | 19 | $2,660 | $1,363 | 51.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 32 | 32 | $2,176 | $1,034 | 47.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 15 | $3,076 | $984.93 | 32.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 15 | $2,955 | $831.79 | 28.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $1,428 | $678.72 | 47.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 41 | 41 | $10,791 | $5,694 | 52.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 14 | 14 | $7,686 | $3,893 | 50.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 37 | $9,314 | $3,602 | 38.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 12 | 12 | $4,572 | $2,148 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 35 | $6,264 | $2,019 | 32.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 13 | $4,742 | $1,891 | 39.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 20 | 23 | $3,904 | $1,111 | 28.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 15 | 15 | $2,020 | $1,022 | 50.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 19 | 19 | $1,247 | $590.82 | 47.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 15 | $1,000 | $466.71 | 46.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 47 | $11,374 | $4,887 | 43.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 32 | 32 | $8,255 | $4,562 | 55.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 34 | 55 | $9,735 | $3,630 | 37.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 17 | 17 | $2,040 | $1,109 | 54.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 18 | 18 | $1,134 | $322.92 | 28.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 12 | 12 | $756.00 | $216.38 | 28.6% |
About Chaimaa Matar
Chaimaa Matar is a Family Medicine healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2010. The National Provider Identifier (NPI) number assigned to this provider is 1942515010.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Chaimaa Matar has received a total of $6,043 in payments from pharmaceutical and medical device companies, with $1,752 received in 2024. These payments were reported across 321 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($6,043).
As a Medicare-enrolled provider, Matar has provided services to 730 Medicare beneficiaries, totaling 819 services with total Medicare billing of $78,034. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Chicago, IL
- Active Since 08/13/2010
- Last Updated 10/30/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1942515010
Products in Payments
- VRAYLAR (Drug) $730.05
- Ozempic (Drug) $401.12
- SHINGRIX (Biological) $252.79
- REXULTI (Drug) $228.60
- Heplisav-B (Drug) $228.04
- Cologuard Collection Kit (Device) $207.05
- FARXIGA (Drug) $196.66
- JARDIANCE (Drug) $192.56
- Wegovy (Drug) $170.04
- Dexcom G6 Transmitter (Medical Supply) $137.96
- Rybelsus (Drug) $135.77
- Saxenda (Drug) $126.79
- Kerendia (Drug) $125.94
- AREXVY (Drug) $123.20
- TRUMENBA (Biological) $121.56
- KRYSTEXXA (Biological) $117.58
- Xofluza (Drug) $105.84
- Doc Band (Device) $104.29
- XIFAXAN (Drug) $103.08
- VOQUEZNA (Drug) $93.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Chicago
Dr. Bradley Torphy, M.d, M.D
Family Medicine — Payments: $1.3M
Family Medicine $1.3M
Dr. Sandy Gibson, D.o, D.O
Family Medicine — Payments: $252,793
Family Medicine $252,793
Igor Altman, D.o, D.O
Family Medicine — Payments: $127,185
Family Medicine $127,185
Ihab Aziz, Md, MD
Family Medicine — Payments: $65,230
Family Medicine $65,230
Dr. Marla Kushner, Do, DO
Family Medicine — Payments: $31,849
Family Medicine $31,849
Dr. Abdulmassih Abdulmassih, M.d, M.D
Family Medicine — Payments: $28,980
Family Medicine $28,980